 |
Journal articles
Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis
Philippe Reix
Aurélie Tatopoulos
Iulia Ioan
Muriel Le Bourgeois
Stéphanie Bui
Marie Luce Choukroun
Katia Bessaci-Kabouya
1
Michele Gerardin
Plamen Bokov
Jennifer da Silva
Jean-Louis Paillasseur
Pierre Regis Burgel
Stéphanie Bui
Author
Marie Luce Choukroun
Author
Katia Bessaci-Kabouya 1
Author
Michele Gerardin
Author
Plamen Bokov
Author
Jennifer da Silva
Author
Jean-Louis Paillasseur
Author
Pierre Regis Burgel
Author
1
P3CELL - Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250 (Inserm UMR-S 1250
CHU Maison-Blanche
45, rue Cognacq-Jay
51092 REIMS Cedex - France)
- URCA - Université de Reims Champagne-Ardenne : UMR-S 1250 (2 avenue Robert Schuman, 51100 Reims. - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : UMR-S 1250 (101, rue de Tolbiac, 75013 Paris - France)
Document type :
Journal articles
Domain :
Complete list of metadata
https://hal.univ-reims.fr/hal-03330701
Contributor : Valerian Dormoy Connect in order to contact the contributor
Submitted on : Wednesday, September 1, 2021 - 10:47:50 AM
Last modification on : Thursday, October 14, 2021 - 1:10:15 PM
Contributor : Valerian Dormoy Connect in order to contact the contributor
Submitted on : Wednesday, September 1, 2021 - 10:47:50 AM
Last modification on : Thursday, October 14, 2021 - 1:10:15 PM
Identifiers
- HAL Id : hal-03330701, version 1
- DOI : 10.1016/j.jcf.2021.06.002
Citation
Philippe Reix, Aurélie Tatopoulos, Iulia Ioan, Muriel Le Bourgeois, Stéphanie Bui, et al.. Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis, Elsevier, 2021, ⟨10.1016/j.jcf.2021.06.002⟩. ⟨hal-03330701⟩
Metrics
Les métriques sont temporairement indisponibles